Publication:
Longitudinal electrocardiographic evaluation of dogs with degenerative mitral valve disease

dc.contributor.authorJ. López-Alvarezen_US
dc.contributor.authorA. Boswooden_US
dc.contributor.authorW. Moonarmarten_US
dc.contributor.authorM. J. Hezzellen_US
dc.contributor.authorN. Lotteren_US
dc.contributor.authorJ. Elliotten_US
dc.contributor.otherRoyal Veterinary College University of Londonen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Pennsylvania, School of Veterinary Medicineen_US
dc.date.accessioned2018-11-09T02:39:29Z
dc.date.available2018-11-09T02:39:29Z
dc.date.issued2014-03-01en_US
dc.description.abstractBackground: Increased heart rate (HR) and decreased heart rate variability (HRV) are evident in some dogs with degenerative mitral valve disease (DMVD). Objectives: Evaluation of the factors influencing HR and HRV (assessed by the vasovagal tonus index; VVTI) and their change over time in dogs with DMVD. Animals: Client-owned dogs (n = 257) with DMVD recruited from first opinion practice. Methods: Prospective longitudinal follow-up at six-monthly intervals of dogs with DMVD. Dogs followed up for at least 18 months (n = 102) were grouped according to their outcome as dogs dying/euthanized because of cardiac disease (n = 28; Group 1), noncardiac disease (n = 40; Group 2) and dogs alive (n = 34; Group 3). HR and VVTI were measured on 1-minute ECG recordings. Repeated measures linear models were constructed to investigate the factors that influence HR and VVTI and their changes over time. Results: Heart rate and VVTI were affected by disease severity and were different in Cavaliers compared to other breeds. Group 1 and Group 2 dogs underwent an increase in HR and decrease in VVTI, evident at least 18 months before death. Group 1 had a further decrease in VVTI followed by an increase in HR approximately 1 year and 6 months before death, respectively. Conclusions and Clinical Importance: Dogs with DMVD have an increase in HR and decrease in HRV over a year before death, with greater changes in those dogs dying/euthanized because of cardiac disease. Both HR and VVTI can potentially be regarded as biomarkers for all-cause mortality. © 2014 by the American College of Veterinary Internal Medicine.en_US
dc.identifier.citationJournal of Veterinary Internal Medicine. Vol.28, No.2 (2014), 393-400en_US
dc.identifier.doi10.1111/jvim.12311en_US
dc.identifier.issn19391676en_US
dc.identifier.issn08916640en_US
dc.identifier.other2-s2.0-84897645697en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/34281
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897645697&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectVeterinaryen_US
dc.titleLongitudinal electrocardiographic evaluation of dogs with degenerative mitral valve diseaseen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897645697&origin=inwarden_US

Files

Collections